BAMS
ALDR

Bellevue Asset Management (Switzerland)’s Alder Biopharmaceuticals ALDR Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$1.09M Sell
33,000
-10,000
-23% -$338K 0.17% 101
2015
Q3 		$1.41M Buy
+43,000
New +$1.83M 0.23% 97

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s ALDR Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) reduced its Alder Biopharmaceuticals (ALDR) stake by 23% in Q4 2015, selling an estimated $338K and leaving 33,000 shares worth $1.09M. The position accounts for 0.17% of the portfolio, ranked #101.

Bellevue Asset Management (Switzerland) first reported a position in ALDR in Q3 2015 and has held it in 2 quarters since. The position peaked at $1.41M in Q3 2015. 134 funds tracked by Wall St. Rank hold ALDR as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 33,000 shares of Alder Biopharmaceuticals worth $1.09M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) sold 10,000 Alder Biopharmaceuticals shares in Q4 2015, an estimated $338K.
  • Alder Biopharmaceuticals made up 0.17% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #101 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Alder Biopharmaceuticals in Q3 2015 and has held it in 2 quarters since.
  • Bellevue Asset Management (Switzerland)'s Alder Biopharmaceuticals position peaked at $1.41M in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.